Oystercal-D Interactions
There are 285 drugs known to interact with Oystercal-D (calcium / vitamin d), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 19 are major, 222 are moderate, and 44 are minor.
- View all 285 medications that may interact with Oystercal-D
- View Oystercal-D alcohol/food interactions (2)
- View Oystercal-D disease interactions (11)
Most frequently checked interactions
View interaction reports for Oystercal-D (calcium / vitamin d) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen
- alendronate
- allopurinol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- BuSpar (buspirone)
- ciclopirox topical
- Colace (docusate)
- divalproex sodium
- docusate
- ferrous sulfate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluticasone nasal
- hydrochlorothiazide
- Lasix (furosemide)
- levothyroxine
- lisinopril
- metoprolol
- Milk of Magnesia (magnesium hydroxide)
- MiraLAX (polyethylene glycol 3350)
- multivitamin
- omeprazole
- PEG3350 (polyethylene glycol 3350)
- simvastatin
- tamsulosin
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
- Zoloft (sertraline)
Oystercal-D alcohol/food interactions
There are 2 alcohol/food interactions with Oystercal-D (calcium / vitamin d).
Oystercal-D disease interactions
There are 11 disease interactions with Oystercal-D (calcium / vitamin d) which include:
- cardiovascular adverse effects
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- hepatobiliary dysfunction
Report options
QR code containing a link to this page
More about Oystercal-D (calcium / vitamin d)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.